Association of common genetic variants in SMAD7 and risk of colon cancer

Carcinogenesis

Volumn 30, Issue 6, 2009, Pages 982-986

  Thompson, Cheryl L ^a,b,c   Plummer, Sarah J ^d   Acheson, Louise S ^a,c   Tucker, Thomas C ^e   Casey, Graham ^d   Li, Li ^a,b,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Case Center for Transdisciplinary Research on Energetics and Cancer   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; SMAD7 PROTEIN; TYROSINE;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; COLON CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; SEX FACTORS; SMAD7 PROTEIN;

EID: 66749148254     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp086     Document Type: Article

References (24)

1. Siegel,P.M. et al. (2003) Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat. Rev. Cancer, 3, 807-821.
2. Roberts,A.B. et al. (2003) The two faces of transforming growth factor β in carcinogenesis. Proc. Natl Acad. Sci. USA, 100, 8621-8623.
3. Glick,A.B. (2004) TGFß1, back to the future: Revisiting its role as a transforming growth factor. Cancer Biol. Ther., 3, 276-283.
4. Xu,Y. et al. (2007) TGF-β signaling alterations and susceptibility to colorectal cancer. Hum. Mol. Genet., 16, R14-R20.
5. Hong,S. et al. (2007) Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat. Immunol., 8, 504-513.
6. Halder,S.K. et al. (2008) Smad7 induces hepatic metastasis in colorectal cancer. Br. J. Cancer, 99, 957-965.
7. Broderick,P. et al. (2007) A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat. Genet., 39, 1315-1317.
8. Tenesa,A. et al. (2008) Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat. Genet., 40, 631-637.
9. Li,L. et al. (2008) Association between phosphatidylinositol 3-Kinase regulatory subunit p85α Met326Ile genetic polymorphism and colon cancer risk. Clin. Cancer Res., 14, 633-637.
10. S.A.G.E. (2007) http://darwin.case.edu. (18 November 2008, date last accessed).
11. Pearson,T.A. et al. (2008) How to interpret a genome-wide association study. JAMA, 299, 1335-1344.
12. Vineis,P. et al. (2008) Expectations and challenges stemming from genome- wide association studies. Mutagenesis, 23, 429-444.
13. Monteleone,G. et al. (2004) Smad7 in TGF-beta-mediated negative regulation of gut inflammation. Trends Immunol., 25, 513-517.
14. Boulay,J.L. et al. (2003) SMAD7 is a prognostic marker in patients with colorectal cancer. Int. J. Cancer, 104, 446-449.
15. Lucia,M.S. et al. (1998) The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells. J. Cell. Physiol., 175 184-192.
16. Komm,B.S. et al. (1988) Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science, 241, 81-84.
17. Arrick,B.A. et al. (1990) Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol. Cancer Res., 50, 299-303.
18. Roberts,A.B. et al. (1992) Mechanistic interrelationships between two superfamilies: The steroid/retinoid receptors and transforming growth factor- β. Cancer Surv., 14, 205-219.
19. Chegini,N. et al. (2003) The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. Mol. Cell. Endocrinol., 209, 9-16.
20. Luo,X. et al. (2003) Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of SMAD in human endometrial epithelial and stromal cells. Reprod. Biol. Endocrinol. 1, 125.
21. Dixon,A. et al. (2007) 17β-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-β protein expression and signaling. Am. J. Physiol. Renal Physiol., 293, F1678-F1690.
22. Tang,Y. et al. (2008) Smad7 stabilizes β-catenin binding to E-cadherin complex and promotes cell-cell adhesion. J. Biol. Chem. 283, 23956-23963.
23. Li,L. et al. (2008) A common 8q24 variant and the risk of colon cancer: A population-based case-control study. Cancer Epidemiol. Biomarkers Prev., 17, 339-342.
24. Potter,J.D. (1999) Colorectal cancer: Molecules and populations. J. Natl Cancer Inst., 91, 916-932.